Phase II Study of Cediranib in Patients With Malignant Pleural Mesothelioma: SWOG S0509
Journal of Thoracic Oncology - United States
doi 10.1097/jto.0b013e318229586e
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2011
Authors
Publisher
Elsevier BV